Ultragenyx CEO Dr. Emil D. Kakkis said federal regulators should focus more on biomarkers and less on clinical endpoints when it comes to drug approvals.
Deep learning is now used to detect disease or abnormalities from x-ray images and classify them into several disease types or severities in radiology.
It has been shown that radiomic features may be useful for predicting patient survival, treatment response, and metastatic potential of tumors.
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Under COVID-19’s lingering shadow, the National Organization of Rare Disorders (NORD) has presented its 2021 Rare Impact Awards to 24 pharmaceutical firms, researchers, politicians, and nonprofit groups for their efforts over the past year on behalf of patients with such illnesses.
Colorado dentist John Abrams had to give up his career because of severe hand cramping — a side effect of the medication he took to control his gastrointestinal stromal tumor (GIST). Monica Anderson, a dental surgeon from Texas, got food poisoning in 2012 after going out with her friends to celebrate a new job. While…
As the super-contagious Delta variant of COVID-19 sweeps across the globe, driving up infection rates as well as deaths, top US health officials are urging everyone 12 and older—including the country’s 30 million or so rare disease patients—to get vaccinated quickly.